Literature DB >> 18164928

Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry.

Yaowalak Boonsongrit1, Bernd W Mueller, Ampol Mitrevej.   

Abstract

Electrostatic interaction between opposite charge of drugs (insulin and benzoic acid) and chitosan was studied by 1H NMR, FTIR and isothermal titration calorimetry (ITC). No ionic interaction between the carboxyl group of benzoic acid and the amine group of chitosan could be detected. There was a minor change in the FTIR spectra of insulin-chitosan microparticles made of different concentrations of insulin. Exothermic heat of reaction between insulin and chitosan was obtained by ITC. However, the measured interaction enthalpy change (delta H) was possibly due to the conformational changes and the adsorption phenomena of insulin onto the surfaces of the particles but not to a binding interaction. The binding of tripolyphosphate, a widely used cross-linking agent, to pH 3.3 and pH 5 chitosan was also studied by ITC. The interaction enthalpy change of the binding between tripolyphosphate and chitosan indicated that tripolyphosphate provided a stronger interaction to pH 5 chitosan than to pH 3.3 chitosan. However, it can be stated that the electrostatical interaction forces between the tested molecules insulin, benzoic acid, and tripolyphosphate and chitosan are found to be very weak.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164928     DOI: 10.1016/j.ejpb.2007.11.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Impact of drying on dissolution behavior of carvedilol-loaded sustained release solid dispersion: development and characterization.

Authors:  Shimul Halder; Fairuza Ahmed; Madhabi Lata Shuma; M A K Azad; Eva Rahman Kabir
Journal:  Heliyon       Date:  2020-09-21

2.  Preparation of a crystalline salt of indomethacin and tromethamine by hot melt extrusion technology.

Authors:  Mustafa Bookwala; Priyanka Thipsay; Samir Ross; Feng Zhang; Suresh Bandari; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2018-08-04       Impact factor: 5.571

Review 3.  Choosing a suitable method for the identification of replication origins in microbial genomes.

Authors:  Chengcheng Song; Shaocun Zhang; He Huang
Journal:  Front Microbiol       Date:  2015-09-30       Impact factor: 5.640

4.  In vivo oral insulin delivery via covalent organic frameworks.

Authors:  Farah Benyettou; Nawel Kaddour; Thirumurugan Prakasam; Gobinda Das; Sudhir Kumar Sharma; Sneha Ann Thomas; Fadia Bekhti-Sari; Jamie Whelan; Mohammed A Alkhalifah; Mostafa Khair; Hassan Traboulsi; Renu Pasricha; Ramesh Jagannathan; Nassima Mokhtari-Soulimane; Felipe Gándara; Ali Trabolsi
Journal:  Chem Sci       Date:  2021-04-06       Impact factor: 9.825

5.  PEGylated Chitosan Nanoparticles Encapsulating Ascorbic Acid and Oxaliplatin Exhibit Dramatic Apoptotic Effects against Breast Cancer Cells.

Authors:  Sherif Ashraf Fahmy; Asmaa Ramzy; Asmaa A Mandour; Soad Nasr; Anwar Abdelnaser; Udo Bakowsky; Hassan Mohamed El-Said Azzazy
Journal:  Pharmaceutics       Date:  2022-02-13       Impact factor: 6.321

6.  Association of Indocyanine Green with Chitosan Oleate Coated PLGA Nanoparticles for Photodynamic Therapy.

Authors:  Dalila Miele; Milena Sorrenti; Laura Catenacci; Paolo Minzioni; Giorgio Marrubini; Valeria Amendola; Marcello Maestri; Paolo Giunchedi; Maria Cristina Bonferoni
Journal:  Pharmaceutics       Date:  2022-08-20       Impact factor: 6.525

7.  Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis.

Authors:  Shiyun Chen; Zhejie Chen; Yi Wang; Wei Hao; Qin Yuan; Hefeng Zhou; Caifang Gao; Yitao Wang; Xu Wu; Shengpeng Wang
Journal:  J Adv Res       Date:  2021-11-29       Impact factor: 12.822

8.  Correlating physicochemical properties of boronic Acid-chitosan conjugates to glucose adsorption sensitivity.

Authors:  Yaa Asantewaa; Jonathan Aylott; Jonathan C Burley; Nashiru Billa; Clive J Roberts
Journal:  Pharmaceutics       Date:  2012-12-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.